Corvus Pharmaceuticals (CRVS) Cash from Investing Activities (QoQ) (2015 - 2026)
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Cash from Investing Activities (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Corvus Pharmaceuticals | 1.33 Bn | 1.12 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.88% |
| Mar 31, 2026 | -1,431.31% |
| Dec 31, 2025 | 515.58% |
| Sep 30, 2025 | 87.10% |
| Jun 30, 2025 | -578.46% |
| Mar 31, 2025 | 169.75% |
| Dec 31, 2024 | -56.38% |
| Sep 30, 2024 | 77.78% |
| Jun 30, 2024 | -249,957.14% |
| Mar 31, 2024 | 99.70% |
| Dec 31, 2023 | -113.21% |
| Sep 30, 2023 | 509.09% |
| Jun 30, 2023 | -193.20% |
| Mar 31, 2023 | 218.55% |
| Dec 31, 2022 | -227.70% |
| Sep 30, 2022 | -3.18% |
| Jun 30, 2022 | 112.28% |
| Mar 31, 2022 | -1,179.34% |
| Dec 31, 2021 | -157.59% |
| Sep 30, 2021 | -77.23% |